Challenges for the development of mutant isocitrate dehydrogenases 1 inhibitors to treat glioma-Reference-Cited by-同舟云学术

Challenges for the development of mutant isocitrate dehydrogenases 1 inhibitors to treat glioma

Published:2023-09 Issue: Volume:257 Page:115464
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Wang Qing-Xin,Zhang Peng-Yu,Li Qing-Qing,Tong Zhen-Jiang,Wu Jia-Zhen,Yu Shao-Peng,Yu Yan-Cheng,Ding Ning,Leng Xue-Jiao,Chang Liang,Xu Jin-Guo,Sun Shan-Liang,Yang Ye,Li Nian-Guang^ORCID,Shi Zhi-Hao

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference169 articles.

1. To be wild or mutant: role of isocitrate dehydrogenase 1 (IDH1) and 2-Hydroxy Glutarate (2-HG) in gliomagenesis and treatment outcome in glioma;Bhavya;Cell. Mol. Neurobiol.,2020

2. The effect and mechanism of LINC00663 on the biological behavior of glioma;Pan;Neurochem. Res.,2021

3. Calcitriol promotes differentiation of glioma stem-like cells and increases their susceptibility to temozolomide;Gerstmeier;Cancers,2021

4. An update on actively targeted liposomes in advanced drug delivery to glioma;Mojarad-Jabali;Int. J. Pharm.,2021

5. Up-Regulation of long non-coding RNA AB073614 predicts a poor prognosis in patients with glioma;Hu;Int. J. Environ. Res. Publ. Health,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of novel natural-product-derived mutant isocitrate dehydrogenases 1 inhibitors: Structure-based virtual screening, biological evaluation and structure-activity relationship study;European Journal of Medicinal Chemistry;2024-09

2. Design and synthesis 1H-Pyrrolo[2,3-b]pyridine derivatives as FLT3 inhibitors for the treatment of Acute myeloid Leukemia;Bioorganic & Medicinal Chemistry;2024-02